Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Short-term Investments: 2020-2023

Historic Short-term Investments for Legend Biotech (LEGN) over the last 3 years, with Dec 2023 value amounting to $663,000.

  • Legend Biotech's Short-term Investments was N/A to -$149.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$149.8 million, marking a year-over-year change of. This contributed to the annual value of $663,000 for FY2023, which is 99.64% down from last year.
  • Legend Biotech's Short-term Investments amounted to $663,000 in FY2023, which was down 99.64% from $185.6 million recorded in FY2022.
  • Over the past 5 years, Legend Biotech's Short-term Investments peaked at $185.6 million during FY2022, and registered a low of -$22.7 million during FY2020.
  • Its 2-year average for Short-term Investments is $93.1 million, with a median of $93.1 million in 2022.
  • Data for Legend Biotech's Short-term Investments shows a maximum YoY plummeted of 99.64% (in 2023) over the last 5 years.
  • Legend Biotech's Short-term Investments (Yearly) stood at -$22.7 million in 2020, then reached $185.6 million in 2022, then plummeted by 99.64% to $663,000 in 2023.